EMFAT
BPMC

Emerald Mutual Fund Advisers Trust’s Blueprint Medicines BPMC Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250,158
Closed -$22.1M – 213
2025
Q1 		$22.1M Sell
250,158
-18,820
-7% -$1.84M 1.57% 14
2024
Q4 		$23.5M Sell
268,978
-19,562
-7% -$1.79M 1.43% 16
2024
Q3 		$26.7M Buy
288,540
+10,207
+4% +$1.01M 1.39% 18
2024
Q2 		$30M Sell
278,333
-37,486
-12% -$3.75M 1.57% 10
2024
Q1 		$30M Sell
315,819
-64,441
-17% -$5.53M 1.56% 12
2023
Q4 		$35.1M Sell
380,260
-84,061
-18% -$5.45M 1.86% 7
2023
Q3 		$23.3M Buy
464,321
+50,994
+12% +$2.72M 1.41% 14
2023
Q2 		$26.1M Buy
413,327
+54,507
+15% +$2.96M 1.42% 11
2023
Q1 		$16.1M Buy
358,820
+53,111
+17% +$2.39M 0.95% 39
2022
Q4 		$13.4M Buy
305,709
+52,064
+21% +$2.5M 0.83% 53
2022
Q3 		$16.7M Buy
+253,645
New +$16.3M 1.06% 33
2022
Q1 		– Sell
-222,217
Closed -$23.8M – 216
2021
Q4 		$23.8M Sell
222,217
-23,340
-10% -$2.44M 0.84% 47
2021
Q3 		$25.2M Hold
245,557
– – 0.87% 46
2021
Q2 		$21.6M Sell
245,557
-33,429
-12% -$3.06M 0.71% 56
2021
Q1 		$27.1M Sell
278,986
-2,753
-1% -$275K 0.9% 35
2020
Q4 		$31.6M Sell
281,739
-82,634
-23% -$8.71M 1.1% 24
2020
Q3 		$33.8M Buy
364,373
+7,071
+2% +$545K 1.5% 14
2020
Q2 		$27.9M Sell
357,302
-6,470
-2% -$438K 1.32% 20
2020
Q1 		$21.3M Buy
+363,772
New +$23.4M 1.33% 19

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's BPMC Position: Q2 2025 in Review

Emerald Mutual Fund Advisers Trust sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 250,158 shares — an estimated $22.1M sold.

Emerald Mutual Fund Advisers Trust first reported a position in BPMC in Q1 2020 and held it in 19 quarters. The position peaked at $35.1M in Q4 2023. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Emerald Mutual Fund Advisers Trust reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 250,158 Blueprint Medicines shares in Q2 2025, an estimated $22.1M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Blueprint Medicines in Q1 2020 and held it in 19 quarters.
  • Emerald Mutual Fund Advisers Trust's Blueprint Medicines position peaked at $35.1M in Q4 2023.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2025, filed 4 Aug 2025.